West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter. Asian Pacific Journal of Cancer Prevention 1513-7368 20 5 2019 05 01 Medical Cost to Treat Cervical Cancer Patients at a Social Security Third Level Oncology Hospital in Mexico City 1547 1554 87868 10.31557/APJCP.2019.20.5.1547 EN Víctor Granados-García Epidemiological and Health Services Research Unit. Aging Area, 21st Century National Medical Center. Mexican Institute of Social Security (IMSS). Mexico City, Mexico. 0000-0002-9075-576X Patricia Piña-Sánchez Unit of Medical Research in Oncological Diseases, UMAE, Oncology Hospital, 21st Century National Medical Center, IMSS. Mexico City, Mexico. Nancy Reynoso-Noveron Research Directorate, National Institute of Cancerology. Mexico City, Mexico. Yvonne N Flores Epidemiological and Health Services Research Unit, Morelos Delegation, IMSS. Cuernavaca Morelos, Mexico. UCLA Department of Health Policy and Management, Cancer Prevention and Control Research, Fielding School of Public, Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. 0000-0002-0601-357X Filiberto Toledano-Toledano Evidence-Based Medicine Research Unit. Children’s Hospital of Mexico Federico Gómez, National Institute of Health. Mexico City, Mexico. Gloria Estrada-Gómez Epidemiological and Health Services Research Unit. Aging Area, 21st Century National Medical Center. Mexican Institute of Social Security (IMSS). Mexico City, Mexico. Teresa Apresa-García Unit of Medical Research in Oncological Diseases, UMAE, Oncology Hospital, 21st Century National Medical Center, IMSS. Mexico City, Mexico. Arely A Briseño Epidemiological and Health Services Research Unit, Morelos Delegation, IMSS. Cuernavaca Morelos, Mexico. 0000-0003-2982-0208 Journal Article 2019 01 16 Background: Cervical Cancer (CC) is an important public health problem worldwide. In 2015, CC was the sixth<br />leading cause of death for women aged 30-59 years in Mexico. Despite the importance of having high-quality and<br />accurate estimates of CC treatment costs that can be used to effectively evaluate the impact of preventive programs, there<br />is scarce information on this topic in Mexico. Objective: To estimate the treatment costs by stage diagnosis in patients<br />with CC at a Mexican Social Security Institute (IMSS) oncology hospital in Mexico City. Methods: An observational<br />retrospective study of the resources used to treat 346 women with CC was conducted. Medical charts were reviewed and<br />relevant resource use information was extracted using a data collection instrument that was created based on treatment<br />guidelines. Data were classified into nine cost categories to estimate the total cost per patient. Results: The mean age<br />of patients in the study sample was 54.3 years (range: 41-67), and the average body mass index (BMI) was >26 kg/m2.<br />Among the participants, 37% were smokers, 39% had diabetes, and 56% had hypertension. The medical cost for stages<br />I-IV ranged from $4,738 to $6,058 USD, with an estimated average cost of $5,114 USD. Conclusion: Total treatment<br />costs per patient are high, especially since they were estimated considering only 7.5 months of treatment. This is the<br />first study to estimate the annual cost to treat CC in Mexico and to additionally document the resource pattern use, cost<br />by stage of cancer, and the distribution by cost categories. https://journal.waocp.org/article_87868_403d900e6ddc340cb1e6c701b14704d2.pdf